LGALS9 and neoplasm: Comparing the immunogenic and non-immunogenic tumor models, we found that Dectin-1+ myeloid cells were significantly enriched with VISTA, TIM-3 and Gal-9 expressing cells in the B16 model while PD-L1 expressing cells were more prominent in the CT26 model (Supplementary Fig. S5A).